Twitter

An off-patent liver disease drug could prevent #COVID19 infection, a new @Nature study has found.

@livuniHLS scientists played a key role in the collaborative study, which involved a unique mix of ‘mini-organs’, donor organs, animal studies & patients.
https://news.liverpool.ac.uk/2022/12/05/off-patent-liver-disease-drug-could-prevent-covid-19-infection/

“This research is our voice. This research is all the voices everyone says they want to hear but no one wants to listen to”.

Research from @livuni, @ucl & @unisouthampton investigates the effects of Covid-19 on children seeking asylum in the UK. ⤵️

http://bit.ly/3UhwmFt

Don't just take my word for it. Here are other sources of information about Group A Strep. https://www.sciencemediacentre.org/expert-reaction-to-uk-strep-a-outbreaks/ and for worried parents worth looking at @Damian_Roland on https://youtu.be/FABmKjCvvvQ https://twitter.com/LBC/status/1599371637870166018

Great to see the @NewtonFund CONNECT study included in this @UKRI_News feature for #WorldAIDSDay

Scientists from @UCT_news and @livuni are working together to assess the impact of HIV therapies in South Africa.

https://medium.com/@UKRI/battling-an-invisible-pandemic-five-ways-researchers-are-fighting-aids-7cb0687e0a85

On Tuesday 6 Dec come along to a free discussion hosted by @LivUniPress and @InstPopMusic about how the Beatles became a worldwide sensation. 🌍🎸🎶

Read more here 👉https://news.liverpool.ac.uk/2022/12/01/best-selling-author-examines-how-the-beatles-became-worldwide-sensation/